Follow Us:

EU MDR

Home Clinical Evaluation Consultants

Free Quote Request
Download
MEDDEV 2.7/1 Rev. 4

Guidelines on Medical Device Clinical Evaluation

File Size (630KB)

Clinical Evaluation Consultants

Clinical Evaluation Consultants

Developing a Clinical Evaluation Report (CER) in accordance with the EU Medical Device Regulation (MDR) 2017/745, MDCG (Medical Device Coordination Group) guidance documents, and MEDDEV guidance documents is a critical task for medical device manufacturers seeking CE Marking certification in the European Union.

 

Due to the complexity of the CER and the stringent requirements set forth in the EU MDR, it is recommended that medical device manufacturers appoint experienced consultants or consulting companies who are knowledgeable in the requirements and have experience in developing CERs for various class and type of devices. These Clinical Evaluation Consultants (CER Consultants) can provide valuable expertise and support in preparing a robust CER that meets notified body requirements and facilitates the early approval of technical documentation.

 

Clinical Evaluation Consultants can help you navigate the complex regulatory landscape and ensure that your CER meets all the necessary requirements. Our Medical Device CER Consultants has cross-platform expertise and in-depth knowledge in MDR Article 61 & Meddev 2.7/1 Rev.4, to start a project right away!

 

Trying to do it in-house could involve employee hiring, training, and providing the support they need, all of which will cost your time, money, and finally no assurance of success.

MDR Clinical Evaluation in Meddev 2.7.1 Rev.4.

MEDDEV 2.7/1 Rev.4 guides the manufacturers on how to undertake a robust and systematic clinical evaluation and how to demonstrate the scientific validity of the data and conclusions. The important changes and corrections in rev.4 are the below.

  • Frequency of updates of the CERs (clause 6.2.3)
  • Qualification of the clinical evaluators or authors (clause 6.4)
  • Requirement of specific objective for the Clinical Evaluation Consultants / report writer which is to be linked to safety performance and risk-benefit endpoints (section 7 and appendix 5)
  • Establishing the State of the Art (clause 8.2)
  • Requirement of scientific validity of different type of dataset (sec 8,9,10 & Appendices: 5,6 & 7)
  • Detailed information on demonstration of equivalence (appendix 1)
  • Information on when a clinical investigation is required (Appendix 2)
  • Some detailed information on risk-benefit (appendix 7.2)
  • Reinforced PMS and PMCF with the clinical evaluation (throughout the guideline)
  • Role and actions required by the notified bodies (appendix 12)

Clinical Evaluation FAQs.

How long does a Notified Body generally take to review the Clinical Evaluation Documents?

Clinical Evaluation Report (CER) review is a part of the Technical Documentation (Technical File / Design Dossier). Generally, 2 months if the NB identifies appropriate Clinical Expert.

How Clinical Evaluation is related to IFU/User Manual?

Contraindications and warnings mentioned in IFU or User Manual must be considered while performing the systematic literature search during Clinical Evaluation. In other way around, IFU or user manual must be modified based on the outcomes of the Clinical Evaluation.

Will a Notified Body would ever inform a company that the clinical evaluation is inadequate, and need data from clinical trial?

Yes, the Notified Body will inform if they require a clinical trial in the below situations and also if the data are insufficient to prove the medical device safety and performance:

  • Where the clinical evidence and clinical data are not relevant and accurate to the device in question
  • If the device is new with respect to technology.
  • If the device is new with respect to use, the material of construction and application.
  • No similar device is available in the market.
  • Multiple recalls on a similar device are reported.

Why the risk management and clinical evaluation process

Clinical risks and residual risks from risk management should be considered for clinical evaluation to prove the safety and similarly, any new risk or adverse effect obtained in clinical evaluation should be reflected in the risk management considering the design or material change, if required.


They are updated regularly to prove the continuing clinical safety and performance of the device or for the need of modification/rejection of device from the market based on the adverse event or new risk observed.

External clinical experts - Who are they? What is there role?

External Clinical Experts are clinical professionals who have expertise in the subject device, chosen and trained by the Notified Body (NB) for the assessment of Clinical Evaluation. They provide advice to the NB with respect to the regulations, guidance, common specifications, and harmonized standards.

Where can I download MDR Article 61?

Readers can download MDR Article 61 (page 55 of 175)

Contact Us